use studi mutat higher implic cell blood tabl level proteom method subgroup follow type cancer present signific signif howev genom includ analys cdna increas increa refer moreov result indic cluster obtain highli lower control molecularli molecular remain genet normal ddpcr array rtqpcr comparison anova perform clinic enabl identifi test adult reaction primer detect ttest consist high handschuh european therefor number observ regul actin factor separ dataset amla valu commonli total verifi select appli experi treat chang cebpa srgn wherea research limit figlerowicz report determin analyz limma version poland regard catalas haematol döhner matur addit databas count marker boutiqu clin concord deg statist actb gapdh ppia product criterion stathmin wilm tumor list crshort crlong journal oncolog small diseas univers sequenc contribut löwenberg induct describ upregul wang engl ding whitman kina statu trend abl distinguish discord revers similar similarli shen huang komarnicki rate mrózek approach standard percentag predict mani fosb kitlg screen tool lymphoma link ptpre despit ighm signatur accord final pvalu adjust partial leuk replic wash time nfkbia potenti serv applic process candid intern diagnosi bmmc grimwad larson posit rhoh sion program annexin oncogen plu leukaemia biol polish marek bone transcript isol hernández tubb tradd powel yang hematol relat particular myeloblast highest involv bergmann wilson biolog uniqu featur garcía complex maurer dissolv mrna kohlmann pbmc modifi tukey cycl biomark yoshida duplic perkinelm acad abund prognosi function distinct induc line avail superscript york growth tert centrifug label equal kaźmierczak oncol szabelska valk mesirov bind inform shown spot guest individu exhibit util gonzález formanowicz materi educ mean median frequent rna context schmidt biophys biophi temperatur global rang ethanol